Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Chief Financial Officer | June 01, 2024 | June 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date June 01, 2024 · Filed June 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 467,827 |
Ending reported balance
After 2024-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-06-01 · Exercise / conversion · Acquired 366,936 · Balance 654,310 Row 2 · 2024-06-03 · Sale · Disposed 186,483 · Balance 467,827 F1: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.74. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 367,046 |
Reported balance
After 2024-06-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-06-01 · Exercise / conversion · Disposed 366,936 · Balance 367,046 F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4: The RSUs vest in three equal annual installments commencing on June 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.74. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date.
F4: The RSUs vest in three equal annual installments commencing on June 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 4, 2024 20:21 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 186,483 | $2.73 | $509,098.59 |
DisclosureSEC source: 0001628280-24-026571 · wk-form4_1717532500.xml · nonDerivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,827 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.74. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:21 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 366,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026571 · wk-form4_1717532500.xml · derivative · entry 3 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,046 Underlying: Class A Common Stock · 366,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on June 1, 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:21 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 366,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026571 · wk-form4_1717532500.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 654,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:19 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 39,323 | $3.63 | $142,742.49 |
DisclosureSEC source: 0001628280-24-009031 · wk-form4_1709677153.xml · nonDerivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,374 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:16 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 397,111 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001628280-24-009451 · wk-form4_1709763403.xml · derivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,111 Underlying: Class A Common Stock · 397,111 shares Expires 2034-03-03 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2024 and in 15 equal quarterly installments thereafter. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:16 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 303,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009451 · wk-form4_1709763403.xml · derivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,030 Underlying: Class A Common Stock · 303,030 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2025. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:19 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 117,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009031 · wk-form4_1709677153.xml · derivative · entry 3 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,055 Underlying: Class A Common Stock · 117,509 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:19 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 117,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009031 · wk-form4_1709677153.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 00:41 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 368 | $4.53 | $1,667.04 |
DisclosureSEC source: 0001628280-24-000354 · wk-form4_1704328859.xml · nonDerivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,188 F2 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the January 1, 2024 vesting of the RSUs described in footnote 1. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:41 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000354 · wk-form4_1704328859.xml · derivative · entry 3 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:41 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000354 · wk-form4_1704328859.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 21:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 158,991 | $5.84 | $928,507.44 |
DisclosureSEC source: 0001628280-23-020902 · wk-form4_1685999182.xml · nonDerivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,556 F1 · kind: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.85. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 366,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020902 · wk-form4_1685999182.xml · derivative · entry 3 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 733,982 Underlying: Class A Common Stock · 366,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on June 1, 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 366,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020902 · wk-form4_1685999182.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:43 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 468,085 | $0.00 Strike: $3.12 | $0.00 |
DisclosureSEC source: 0001628280-23-006728 · wf-form4_167822540329940.xml · derivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,085 Underlying: Class A Common Stock · 468,085 shares Expires 2033-03-02 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2023 and in 15 equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:43 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 352,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006728 · wf-form4_167822540329940.xml · derivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,564 Underlying: Class A Common Stock · 352,564 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:25 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 388 | $2.37 | $919.56 |
DisclosureSEC source: 0001628280-23-000778 · wf-form4_167330672031352.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000360 · wf-form4_167288194101803.xml · derivative · entry 2 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Class A Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · shares: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantClass A Common Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000360 · wf-form4_167288194101803.xml · nonDerivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · shares: On June 1, 2022, the reporting person was granted 2,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 1,100,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-067614 · tm2216781-2_4seq1.xml · derivative · entry 1 Donohue Mark · CIK 0001930278 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,917 Underlying: Class A Common Stock · 1,100,917 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on June 1, 2023. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.